IL17A and pulmonary fibrosis: By contrast, using mice deficient for IL-17 signaling or treated with anti-IL-17 antibodies, we show reduced inflammation in the bronchoalveolar space and in interstitium inflammation and confirmed two studies reporting that IL-17 has a detrimental role in lung fibrosis [6], [11].